Guanylate Cyclase-C Agonist [EPC]

Guanylate Cyclase-C Agonist [EPC] was reported 2075 times

Drugs of the Guanylate Cyclase-C Agonist [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 GASTROINTESTINAL MOTILITY DISORDER 191 0.0356
1 THERAPEUTIC PRODUCT EFFECT INCREASED 38 0.0326
2 FAECES HARD 126 0.0323
3 INFREQUENT BOWEL MOVEMENTS 73 0.0293
4 FAECAL VOLUME INCREASED 14 0.0269
5 DYSCHEZIA 81 0.0265
6 RECTAL TENESMUS 33 0.0265
7 BOWEL MOVEMENT IRREGULARITY 195 0.0254
8 GASTROINTESTINAL HYPOMOTILITY 50 0.0222
9 ANAL INCONTINENCE 189 0.0210
10 CERVICAL RADICULOPATHY 14 0.0196
11 THERAPEUTIC RESPONSE INCREASED 18 0.0191
12 RECTAL PROLAPSE 23 0.0190
13 GASTROINTESTINAL SOUNDS ABNORMAL 90 0.0181
14 DEFAECATION DISORDER 12 0.0179
15 VOLVULUS 40 0.0169
16 DEFAECATION URGENCY 116 0.0165
17 IMPAIRED GASTRIC EMPTYING 215 0.0158
18 ABNORMAL FAECES 128 0.0156
19 DRUG EFFECT VARIABLE 17 0.0150
20 PATIENT DISSATISFACTION WITH TREATMENT 28 0.0145
21 THERAPEUTIC PRODUCT EFFECT VARIABLE 56 0.0144
22 OBSTRUCTIVE SLEEP APNOEA SYNDROME 21 0.0144
23 REBOUND ACID HYPERSECRETION 43 0.0142
24 FLATULENCE 784 0.0138
25 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 14 0.0132
26 GASTRIC DILATATION 22 0.0132
27 ABDOMINAL DISTENSION 1294 0.0124
28 PRODUCT DISPENSING ERROR 268 0.0123
29 NEPHROGENIC ANAEMIA 56 0.0121
30 HYPERPARATHYROIDISM SECONDARY 30 0.0120
31 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 15 0.0111
32 PHYSICAL PRODUCT LABEL ISSUE 13 0.0109
33 DRY AGE-RELATED MACULAR DEGENERATION 12 0.0108
34 CONSTIPATION 2210 0.0101
35 FUNCTIONAL GASTROINTESTINAL DISORDER 35 0.0101
36 PRODUCT ADMINISTRATION INTERRUPTED 77 0.0098
37 INFUSION SITE DISCHARGE 17 0.0097
38 FAECALOMA 52 0.0095
39 ESSENTIAL HYPERTENSION 17 0.0093
40 INFUSION SITE PRURITUS 29 0.0092
41 CATAPLEXY 13 0.0092
42 PROCTALGIA 59 0.0092
43 PRE-EXISTING CONDITION IMPROVED 57 0.0091
44 INFUSION SITE HAEMORRHAGE 30 0.0091
45 MEDICAL DEVICE IMPLANTATION 14 0.0089
46 BLADDER DISCOMFORT 11 0.0088
47 CYSTITIS INTERSTITIAL 14 0.0087
48 PRODUCT PHYSICAL ISSUE 171 0.0085
49 SINUS OPERATION 19 0.0080
50 DIARRHOEA 5139 0.0080
51 GASTROINTESTINAL PAIN 87 0.0079
52 ANORECTAL DISCOMFORT 41 0.0077
53 THERAPEUTIC RESPONSE DELAYED 21 0.0075
54 WRONG DOSE 17 0.0070
55 THERAPEUTIC PRODUCT EFFECT DELAYED 32 0.0070
56 INFUSION SITE BRUISING 15 0.0069
57 FAECAL INCONTINENCE 33 0.0069
58 FREQUENT BOWEL MOVEMENTS 183 0.0068
59 IRRITABLE BOWEL SYNDROME 145 0.0068
60 LARGE INTESTINAL OBSTRUCTION 15 0.0067
61 OESOPHAGEAL SPASM 12 0.0065
62 FAECES DISCOLOURED 141 0.0065
63 INABILITY TO AFFORD MEDICATION 64 0.0064
64 INSURANCE ISSUE 98 0.0064
65 PRODUCT LOT NUMBER ISSUE 14 0.0063
66 STOMA SITE DISCHARGE 17 0.0062
67 MALABSORPTION 32 0.0061
68 INTENTIONAL PRODUCT MISUSE 533 0.0061
69 SPINAL OPERATION 73 0.0059
70 THERAPEUTIC PRODUCT EFFECT DECREASED 264 0.0059
71 ENDOMETRIOSIS 28 0.0059
72 SHOULDER OPERATION 25 0.0058
73 HAEMORRHOIDS 113 0.0058
74 HAEMORRHOIDAL HAEMORRHAGE 28 0.0057
75 BRAIN OPERATION 13 0.0057
76 DEVICE INFUSION ISSUE 14 0.0056
77 ORAL SURGERY 13 0.0056
78 ABDOMINAL RIGIDITY 15 0.0055
79 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 393 0.0055
80 ANORECTAL DISORDER 11 0.0055
81 POOR QUALITY PRODUCT ADMINISTERED 58 0.0055
82 FAECES SOFT 40 0.0055
83 INTESTINAL OBSTRUCTION 202 0.0054
84 PRODUCT STORAGE ISSUE 20 0.0053
85 OBSTRUCTION 21 0.0053
86 EYE CONTUSION 11 0.0052
87 EXPIRED PRODUCT ADMINISTERED 172 0.0052
88 PRODUCT PACKAGING ISSUE 49 0.0052
89 NECK SURGERY 12 0.0052
90 ABDOMINAL PAIN UPPER 1061 0.0051
91 PRODUCT CONTAMINATION PHYSICAL 13 0.0051
92 ABDOMINAL PAIN 1186 0.0051
93 DRUG DISPENSING ERROR 77 0.0050
94 DRUG TITRATION ERROR 13 0.0050
95 SNORING 19 0.0050
96 VITAMIN B12 DEFICIENCY 20 0.0049
97 INCORRECT DRUG ADMINISTRATION RATE 21 0.0049
98 END STAGE RENAL DISEASE 89 0.0049
99 FREEZING PHENOMENON 18 0.0049
100 SHOULDER ARTHROPLASTY 13 0.0048
101 INTENTIONAL DOSE OMISSION 137 0.0048
102 EAR CONGESTION 13 0.0048
103 PRODUCT STORAGE ERROR 417 0.0048
104 PARANASAL SINUS DISCOMFORT 18 0.0048
105 ILEUS 59 0.0047
106 DRUG EFFECT INCREASED 15 0.0047
107 NONSPECIFIC REACTION 26 0.0047
108 SEASONAL ALLERGY 66 0.0047
109 REGURGITATION 16 0.0047
110 THERAPEUTIC RESPONSE DECREASED 282 0.0046
111 LARGE INTESTINE POLYP 32 0.0046
112 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 826 0.0046
113 PRODUCT LABEL ISSUE 31 0.0046
114 CHRONIC KIDNEY DISEASE 346 0.0045
115 MULTIPLE ALLERGIES 35 0.0045
116 PRODUCT DISPENSING ISSUE 19 0.0044
117 NECK INJURY 13 0.0044
118 DIVERTICULITIS 121 0.0044
119 INFUSION SITE PAIN 56 0.0043
120 CYSTIC FIBROSIS 24 0.0043
121 VULVOVAGINAL MYCOTIC INFECTION 17 0.0043
122 INCORRECT DOSAGE ADMINISTERED 21 0.0043
123 SURGERY 251 0.0043
124 MUSCLE STRAIN 37 0.0043
125 INFUSION SITE ERYTHEMA 36 0.0043
126 MUCOUS STOOLS 21 0.0042
127 HEREDITARY ANGIOEDEMA 45 0.0042
128 KNEE OPERATION 41 0.0042
129 HYPERTONIC BLADDER 12 0.0042
130 BLOOD CREATININE DECREASED 13 0.0041
131 INFUSION SITE SWELLING 26 0.0041
132 VITAMIN D DEFICIENCY 40 0.0041
133 EPIGASTRIC DISCOMFORT 16 0.0041
134 FEEDING DISORDER 82 0.0040
135 FOOT OPERATION 20 0.0040
136 OFF LABEL USE 3465 0.0040
137 HOSPICE CARE 39 0.0039
138 EYE OPERATION 18 0.0039
139 PRODUCT PRESCRIBING ERROR 93 0.0039
140 BRAIN FOG 61 0.0039
141 INCONTINENCE 41 0.0039
142 INFUSION SITE EXTRAVASATION 24 0.0039
143 HIATUS HERNIA 49 0.0038
144 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 207 0.0038
145 LIMB OPERATION 18 0.0037
146 SINUS DISORDER 74 0.0037
147 INTRACRANIAL ANEURYSM 15 0.0037
148 CHRONIC SINUSITIS 14 0.0037
149 ABDOMINAL HERNIA 17 0.0037
150 BLADDER DISORDER 37 0.0037
151 BLOOD POTASSIUM DECREASED 112 0.0037
152 PARANASAL SINUS HYPERSECRETION 14 0.0037
153 THYROID MASS 14 0.0036
154 DRUG PRESCRIBING ERROR 70 0.0036
155 SPINAL STENOSIS 15 0.0036
156 ILLNESS 374 0.0036
157 SLEEP APNOEA SYNDROME 69 0.0036
158 LYME DISEASE 12 0.0036
159 DRUG INEFFECTIVE 4740 0.0036
160 ORAL INFECTION 14 0.0036
161 COLITIS ISCHAEMIC 24 0.0036
162 DELUSION 55 0.0035
163 COLECTOMY 20 0.0035
164 PRODUCT RESIDUE PRESENT 19 0.0035
165 UNEVALUABLE EVENT 266 0.0035
166 VITAMIN D DECREASED 30 0.0035
167 SYMPTOM RECURRENCE 21 0.0035
168 GASTROOESOPHAGEAL REFLUX DISEASE 282 0.0035
169 CONCUSSION 27 0.0035
170 ABDOMINAL ADHESIONS 11 0.0035
171 LYMPHOEDEMA 24 0.0035
172 ERUCTATION 67 0.0035
173 PRODUCT DISTRIBUTION ISSUE 32 0.0034
174 POST-TRAUMATIC STRESS DISORDER 23 0.0034
175 INTENTIONAL UNDERDOSE 25 0.0034
176 GASTROINTESTINAL DISORDER 305 0.0034
177 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 21 0.0034
178 SKIN ABRASION 16 0.0034
179 BACK DISORDER 55 0.0034
180 FOOD ALLERGY 26 0.0034
181 IRON DEFICIENCY 15 0.0033
182 CHOLECYSTECTOMY 38 0.0033
183 HIP SURGERY 18 0.0033
184 DEHYDRATION 443 0.0033
185 DRUG EFFECT DELAYED 15 0.0033
186 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 18 0.0033
187 DISABILITY 65 0.0033
188 HERNIA 63 0.0033
189 IRON DEFICIENCY ANAEMIA 30 0.0032
190 ON AND OFF PHENOMENON 18 0.0032
191 INTERVERTEBRAL DISC DEGENERATION 30 0.0032
192 MICTURITION URGENCY 37 0.0032
193 ABDOMINAL DISCOMFORT 543 0.0032
194 DIVERTICULUM 23 0.0032
195 HYSTERECTOMY 28 0.0032
196 ABDOMINAL TENDERNESS 16 0.0032
197 MALNUTRITION 36 0.0032
198 GALLBLADDER OPERATION 13 0.0032
199 POST PROCEDURAL INFECTION 26 0.0032
200 PRODUCT SOLUBILITY ABNORMAL 16 0.0032
201 NEURALGIA 77 0.0032
202 ILEUS PARALYTIC 14 0.0031
203 THERAPY INTERRUPTED 224 0.0031
204 BLOOD MAGNESIUM DECREASED 27 0.0031
205 REHABILITATION THERAPY 12 0.0031
206 FEELING OF BODY TEMPERATURE CHANGE 18 0.0031
207 TONGUE DISCOMFORT 13 0.0031
208 FOOT FRACTURE 58 0.0031
209 POLYP 20 0.0031
210 DECREASED INTEREST 18 0.0030
211 SKIN ODOUR ABNORMAL 12 0.0030
212 HEART RATE ABNORMAL 17 0.0030
213 SOMNAMBULISM 20 0.0030
214 ROTATOR CUFF SYNDROME 39 0.0030
215 RECTAL HAEMORRHAGE 130 0.0030
216 HALLUCINATION 228 0.0030
217 DEVICE KINK 11 0.0030
218 ELECTROLYTE IMBALANCE 35 0.0030
219 HORDEOLUM 13 0.0030
220 OROPHARYNGEAL DISCOMFORT 27 0.0030
221 ANAL FISSURE 16 0.0030
222 SENSITIVE SKIN 22 0.0030
223 URINE OUTPUT DECREASED 26 0.0030
224 MIGRAINE 283 0.0030
225 HAND FRACTURE 21 0.0030
226 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 142 0.0030
227 DYSPEPSIA 290 0.0029
228 HEAD INJURY 93 0.0029
229 FIBROMYALGIA 71 0.0029
230 RESTLESS LEGS SYNDROME 53 0.0029
231 VULVOVAGINAL PAIN 14 0.0029
232 KIDNEY INFECTION 57 0.0029
233 RESPIRATION ABNORMAL 20 0.0029
234 INTERVERTEBRAL DISC PROTRUSION 63 0.0029
235 BRADYKINESIA 17 0.0029
236 GAIT INABILITY 96 0.0029
237 APPETITE DISORDER 19 0.0029
238 CARDIAC PACEMAKER INSERTION 17 0.0028
239 SKIN LACERATION 31 0.0028
240 MUSCLE SPASMS 523 0.0028
241 ABDOMINAL PAIN LOWER 72 0.0028
242 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 201 0.0028
243 PRODUCT ADMINISTRATION ERROR 57 0.0028
244 EATING DISORDER 60 0.0028
245 BLOOD PRESSURE DIASTOLIC INCREASED 13 0.0028
246 BLOOD SODIUM DECREASED 53 0.0028
247 PRODUCT USE COMPLAINT 44 0.0028
248 GASTROINTESTINAL INFECTION 25 0.0028
249 DIZZINESS POSTURAL 27 0.0028
250 SUSPECTED SUICIDE 13 0.0028
251 TIBIA FRACTURE 13 0.0028
252 MENISCUS INJURY 17 0.0028
253 SMALL INTESTINAL OBSTRUCTION 34 0.0028
254 BIPOLAR DISORDER 30 0.0028
255 THIRST 49 0.0027
256 LIGAMENT SPRAIN 27 0.0027
257 WALKING AID USER 18 0.0027
258 THYROID DISORDER 42 0.0027
259 IMPAIRED QUALITY OF LIFE 39 0.0027
260 BENIGN PROSTATIC HYPERPLASIA 14 0.0027
261 COVID-19 PNEUMONIA 32 0.0027
262 GLUCOSE TOLERANCE IMPAIRED 16 0.0027
263 NERVE INJURY 30 0.0027
264 GASTRITIS 71 0.0027
265 BLOOD IRON DECREASED 32 0.0027
266 SINUSITIS 276 0.0027
267 PHARYNGITIS STREPTOCOCCAL 29 0.0027
268 KNEE ARTHROPLASTY 56 0.0027
269 GASTROENTERITIS VIRAL 48 0.0027
270 DRY THROAT 27 0.0027
271 CARPAL TUNNEL SYNDROME 37 0.0026
272 DISCOMFORT 161 0.0026
273 PANCREATIC DISORDER 13 0.0026
274 PRODUCT DOSE OMISSION 171 0.0026
275 SPINAL OSTEOARTHRITIS 23 0.0026
276 HAEMATOCHEZIA 143 0.0026
277 ORAL DISCOMFORT 36 0.0026
278 WRIST FRACTURE 31 0.0026
279 SCOLIOSIS 16 0.0026
280 WEIGHT FLUCTUATION 27 0.0026
281 URINARY TRACT INFECTION 439 0.0026
282 DIARRHOEA HAEMORRHAGIC 24 0.0026
283 DYSKINESIA 104 0.0026
284 DERMATITIS CONTACT 29 0.0025
285 POSTOPERATIVE WOUND INFECTION 17 0.0025
286 MIDDLE INSOMNIA 47 0.0025
287 DYSPHEMIA 11 0.0025
288 OCULAR DISCOMFORT 28 0.0025
289 BLOOD PRESSURE ABNORMAL 49 0.0025
290 PERONEAL NERVE PALSY 14 0.0025
291 HORMONE LEVEL ABNORMAL 12 0.0025
292 ORAL DISORDER 18 0.0025
293 ANKLE FRACTURE 38 0.0025
294 FLANK PAIN 23 0.0025
295 LARGE INTESTINE PERFORATION 17 0.0024
296 INITIAL INSOMNIA 25 0.0024
297 CEREBRAL DISORDER 18 0.0024
298 MACULAR DEGENERATION 29 0.0024
299 EYE PAIN 137 0.0024
300 COMPRESSION FRACTURE 13 0.0024
301 PRODUCT SIZE ISSUE 13 0.0024
302 EAR PAIN 47 0.0024
303 INTESTINAL RESECTION 13 0.0024
304 ANEURYSM 12 0.0024
305 MUSCLE TIGHTNESS 39 0.0024
306 HYPERSOMNIA 69 0.0024
307 FLUID INTAKE REDUCED 12 0.0024
308 DYSSTASIA 70 0.0024
309 GROIN PAIN 21 0.0024
310 URINE ODOUR ABNORMAL 14 0.0024
311 FLUID RETENTION 121 0.0024
312 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 480 0.0024
313 FALL 786 0.0024
314 UPPER RESPIRATORY TRACT INFECTION 109 0.0024
315 RHINITIS 19 0.0024
316 TOOTH INFECTION 31 0.0023
317 COELIAC DISEASE 23 0.0023
318 POST PROCEDURAL COMPLICATION 45 0.0023
319 NEPHROLITHIASIS 107 0.0023
320 BRONCHITIS 172 0.0023
321 THERAPEUTIC RESPONSE UNEXPECTED 104 0.0023
322 INCOHERENT 15 0.0023
323 HEAD DISCOMFORT 41 0.0023
324 UPPER-AIRWAY COUGH SYNDROME 19 0.0023
325 GASTROINTESTINAL INFLAMMATION 18 0.0023
326 DYSPHAGIA 218 0.0023
327 CYSTITIS 73 0.0023
328 HIP ARTHROPLASTY 35 0.0023
329 DYSURIA 84 0.0023
330 DYSGRAPHIA 15 0.0023
331 DRY MOUTH 184 0.0023
332 PRESCRIBED UNDERDOSE 45 0.0023
333 GASTRIC DISORDER 77 0.0022
334 EAR DISCOMFORT 23 0.0022
335 OSTEOARTHRITIS 95 0.0022
336 NASAL DRYNESS 14 0.0022
337 TEMPERATURE INTOLERANCE 23 0.0022
338 BALANCE DISORDER 192 0.0022
339 FUNGAL INFECTION 74 0.0022
340 BACK INJURY 24 0.0022
341 PRODUCT DOSE OMISSION ISSUE 648 0.0022
342 ENERGY INCREASED 13 0.0022
343 OVARIAN CYST 22 0.0022
344 SINUS HEADACHE 13 0.0022
345 THERAPY CESSATION 112 0.0022
346 HALLUCINATION, VISUAL 46 0.0022
347 OSTEOPENIA 33 0.0022
348 LIMB INJURY 59 0.0022
349 NECK PAIN 121 0.0022
350 AFFECTIVE DISORDER 17 0.0022
351 PERIPHERAL SWELLING 333 0.0022
352 POLLAKIURIA 90 0.0022
353 PRODUCT DOSE OMISSION IN ERROR 61 0.0022
354 PRODUCT COMMUNICATION ISSUE 19 0.0022
355 HUNGER 30 0.0022
356 DRY EYE 107 0.0021
357 BLOOD ALBUMIN DECREASED 17 0.0021
358 RENAL CYST 17 0.0021
359 RESPIRATORY TRACT CONGESTION 34 0.0021
360 TUBULOINTERSTITIAL NEPHRITIS 40 0.0021
361 LOWER LIMB FRACTURE 41 0.0021
362 CANDIDA INFECTION 36 0.0021
363 URINARY RETENTION 71 0.0021
364 ORAL CANDIDIASIS 28 0.0021
365 POOR VENOUS ACCESS 22 0.0021
366 SLEEP DISORDER 150 0.0021
367 PERIORBITAL SWELLING 12 0.0021
368 HIP FRACTURE 68 0.0021
369 RETCHING 45 0.0021
370 NASAL CONGESTION 124 0.0021
371 NAUSEA 1669 0.0021
372 ORAL PAIN 47 0.0021
373 DRUG EFFECT LESS THAN EXPECTED 31 0.0021
374 RIB FRACTURE 43 0.0021
375 DRUG DOSE OMISSION 345 0.0021
376 INCORRECT DOSE ADMINISTERED 475 0.0021
377 EXOSTOSIS 19 0.0021
378 COLON CANCER 31 0.0021
379 MOUTH SWELLING 12 0.0021
380 PYELONEPHRITIS 18 0.0021
381 SECRETION DISCHARGE 26 0.0021
382 SWELLING OF EYELID 13 0.0021
383 ORTHOSTATIC HYPOTENSION 36 0.0021
384 WEIGHT INCREASED 462 0.0021
385 DEVICE OCCLUSION 29 0.0021
386 NERVE COMPRESSION 19 0.0021
387 PROCEDURAL PAIN 57 0.0021
388 OROPHARYNGEAL PAIN 190 0.0021
389 NERVOUSNESS 107 0.0020
390 PHARYNGEAL SWELLING 20 0.0020
391 WEIGHT DECREASED 570 0.0020
392 BACK PAIN 474 0.0020
393 FEELING DRUNK 15 0.0020
394 FACIAL PAIN 18 0.0020
395 DECREASED APPETITE 468 0.0020
396 SCIATICA 32 0.0020
397 DRUG EFFECT DECREASED 108 0.0020
398 LIMB DISCOMFORT 62 0.0020
399 SPUTUM DISCOLOURED 19 0.0020
400 POOR QUALITY SLEEP 43 0.0020
401 COVID-19 349 0.0020
402 INTENTIONAL PRODUCT USE ISSUE 174 0.0020
403 LOCALISED INFECTION 48 0.0020
404 FRUSTRATION TOLERANCE DECREASED 16 0.0020
405 CARDIAC OPERATION 17 0.0020
406 PHOTOPHOBIA 37 0.0020
407 ARTERIOSCLEROSIS CORONARY ARTERY 13 0.0020
408 THROAT IRRITATION 88 0.0020
409 URINARY INCONTINENCE 58 0.0020
410 FEELING ABNORMAL 469 0.0020
411 RESPIRATORY SYNCYTIAL VIRUS INFECTION 17 0.0020
412 CARDIAC FAILURE ACUTE 13 0.0019
413 MEMORY IMPAIRMENT 268 0.0019
414 DYSPHONIA 114 0.0019
415 CHROMATURIA 44 0.0019
416 BLOOD URINE PRESENT 37 0.0019
417 PULMONARY MASS 29 0.0019
418 DECREASED ACTIVITY 21 0.0019
419 OSTEOPOROSIS 80 0.0019
420 BLOOD PRESSURE DECREASED 129 0.0019
421 RENAL TUBULAR NECROSIS 19 0.0019
422 DIZZINESS 964 0.0019
423 THERAPY CHANGE 19 0.0019
424 SCAR 33 0.0019
425 PELVIC FRACTURE 15 0.0019
426 RENAL INJURY 57 0.0019
427 UPPER LIMB FRACTURE 38 0.0019
428 SEIZURE 220 0.0019
429 BEDRIDDEN 25 0.0019
430 ANXIETY 541 0.0019
431 NOCTURIA 23 0.0019
432 THERAPEUTIC RESPONSE CHANGED 12 0.0019
433 JOINT DISLOCATION 20 0.0019
434 TREMOR 314 0.0019
435 MUSCULOSKELETAL DISORDER 36 0.0019
436 DEPRESSION 429 0.0019
437 FOREIGN BODY SENSATION IN EYES 12 0.0019
438 MULTIPLE SCLEROSIS 90 0.0019
439 RESPIRATORY TRACT INFECTION 49 0.0019
440 PALPITATIONS 220 0.0019
441 THINKING ABNORMAL 35 0.0019
442 ASTHENIA 706 0.0019
443 FORMICATION 13 0.0019
444 PRODUCT CONTAINER ISSUE 16 0.0019
445 TOOTH ABSCESS 19 0.0019
446 PANIC ATTACK 68 0.0019
447 CARDIAC FLUTTER 12 0.0019
448 CONTUSION 178 0.0018
449 HEADACHE 1156 0.0018
450 PRODUCTIVE COUGH 88 0.0018
451 FEELING JITTERY 35 0.0018
452 BLOOD PRESSURE FLUCTUATION 44 0.0018
453 FEELING COLD 51 0.0018
454 NAIL DISORDER 16 0.0018
455 EYE DISCHARGE 19 0.0018
456 BLOOD GLUCOSE FLUCTUATION 20 0.0018
457 TENDERNESS 19 0.0018
458 TOOTHACHE 33 0.0018
459 PRODUCT SUPPLY ISSUE 13 0.0018
460 COLITIS 69 0.0018
461 DENTAL CARIES 20 0.0018
462 SOMNOLENCE 363 0.0018
463 PAIN IN JAW 51 0.0018
464 PRODUCT PRESCRIBING ISSUE 39 0.0018
465 GASTRIC ULCER 34 0.0018
466 BREAST MASS 12 0.0018
467 CHEST PAIN 330 0.0018
468 MAJOR DEPRESSION 13 0.0018
469 SINUS CONGESTION 24 0.0018
470 THROAT TIGHTNESS 48 0.0018
471 BLOOD PRESSURE INCREASED 271 0.0018
472 EAR INFECTION 47 0.0018
473 MULTIPLE SCLEROSIS RELAPSE 121 0.0018
474 CHOLECYSTITIS 21 0.0018
475 ABNORMAL LOSS OF WEIGHT 12 0.0018
476 HYPOPHOSPHATAEMIA 13 0.0018
477 ACCIDENT 21 0.0018
478 HYPERLIPIDAEMIA 21 0.0018
479 PAIN 1079 0.0018
480 COGNITIVE DISORDER 82 0.0018
481 GAIT DISTURBANCE 335 0.0017
482 MYASTHENIA GRAVIS 14 0.0017
483 PARAESTHESIA ORAL 25 0.0017
484 TASTE DISORDER 35 0.0017
485 MALAISE 756 0.0017
486 TOOTH FRACTURE 19 0.0017
487 COMPLICATION ASSOCIATED WITH DEVICE 25 0.0017
488 PNEUMONIA ASPIRATION 43 0.0017
489 RENAL FAILURE 228 0.0017
490 HEART RATE INCREASED 170 0.0017
491 BACTERIAL INFECTION 32 0.0017
492 VIRAL INFECTION 57 0.0017
493 ANHEDONIA 45 0.0017
494 INSOMNIA 456 0.0017
495 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 29 0.0017
496 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 89 0.0017
497 SALIVARY HYPERSECRETION 17 0.0017
498 HYPOTHYROIDISM 54 0.0017
499 VERTIGO 103 0.0017
500 THERAPEUTIC RESPONSE SHORTENED 56 0.0017
501 BREAST PAIN 18 0.0017
502 FATIGUE 1314 0.0017
503 TOOTH EXTRACTION 21 0.0017
504 EYE IRRITATION 97 0.0017
505 SPEECH DISORDER 88 0.0017
506 PRODUCT USE ISSUE 315 0.0017
507 ASTHMA 189 0.0017
508 GOUT 30 0.0017
509 MOUTH ULCERATION 35 0.0017
510 TRANSIENT ISCHAEMIC ATTACK 56 0.0017
511 TONGUE DISORDER 12 0.0017
512 ELECTROCARDIOGRAM ABNORMAL 13 0.0017
513 LIP DRY 15 0.0016
514 LETHARGY 95 0.0016
515 APHONIA 23 0.0016
516 HYPERHIDROSIS 212 0.0016
517 PRESYNCOPE 40 0.0016
518 WOUND INFECTION 18 0.0016
519 MOBILITY DECREASED 118 0.0016
520 GINGIVAL PAIN 13 0.0016
521 BRONCHIECTASIS 11 0.0016
522 TINNITUS 75 0.0016
523 PRODUCT USE IN UNAPPROVED INDICATION 404 0.0016
524 MUSCULOSKELETAL DISCOMFORT 28 0.0016
525 PRODUCT TASTE ABNORMAL 22 0.0016
526 GALLBLADDER DISORDER 29 0.0016
527 LOWER GASTROINTESTINAL HAEMORRHAGE 12 0.0016
528 OBSESSIVE-COMPULSIVE DISORDER 13 0.0016
529 ARTHROPOD BITE 12 0.0016
530 SEROTONIN SYNDROME 31 0.0016
531 SKIN SWELLING 14 0.0016
532 LYMPHADENOPATHY 57 0.0016
533 MENTAL DISORDER 70 0.0016
534 APPENDICITIS 15 0.0016
535 SKIN INFECTION 18 0.0016
536 HYPOPHAGIA 41 0.0016
537 INTESTINAL PERFORATION 18 0.0016
538 SPINAL FRACTURE 32 0.0016
539 DECUBITUS ULCER 13 0.0016
540 ABNORMAL DREAMS 44 0.0016
541 MUSCULAR WEAKNESS 181 0.0016
542 DROOLING 11 0.0016
543 EYE SWELLING 59 0.0016
544 SPINAL DISORDER 15 0.0016
545 MUSCLE ATROPHY 20 0.0016
546 INFLUENZA 176 0.0016
547 SPINAL COMPRESSION FRACTURE 13 0.0016
548 ACUTE KIDNEY INJURY 240 0.0016
549 RENAL DISORDER 73 0.0016
550 VOMITING 732 0.0016
551 SKIN HAEMORRHAGE 23 0.0016
552 NIGHT SWEATS 50 0.0016
553 HEART RATE IRREGULAR 35 0.0015
554 MUSCLE SPASTICITY 19 0.0015
555 NEUROPATHY PERIPHERAL 147 0.0015
556 RESPIRATORY DISORDER 46 0.0015
557 CHEST DISCOMFORT 157 0.0015
558 HYPOACUSIS 66 0.0015
559 NODULE 20 0.0015
560 COLD SWEAT 27 0.0015
561 LYMPHOCYTE COUNT DECREASED 27 0.0015
562 PRURITUS GENERALISED 33 0.0015
563 FACIAL PARALYSIS 13 0.0015
564 SNEEZING 34 0.0015
565 FURUNCLE 12 0.0015
566 NASAL DISCOMFORT 12 0.0015
567 ARTHRITIS 119 0.0015
568 ULCER 24 0.0015
569 EYE INFECTION 17 0.0015
570 HYPOAESTHESIA 225 0.0015
571 IMPAIRED DRIVING ABILITY 17 0.0015
572 CHOLELITHIASIS 49 0.0015
573 DEAFNESS 39 0.0015
574 ORAL HERPES 29 0.0015
575 FEELING HOT 91 0.0015
576 TOOTH DISORDER 33 0.0015
577 BLOOD POTASSIUM INCREASED 24 0.0015
578 HYPOKALAEMIA 68 0.0015
579 LOSS OF CONSCIOUSNESS 188 0.0015
580 PAIN IN EXTREMITY 432 0.0015
581 HICCUPS 12 0.0015
582 DYSPNOEA EXERTIONAL 55 0.0015
583 PHOTOSENSITIVITY REACTION 24 0.0015
584 HEART RATE DECREASED 51 0.0015
585 JOINT INJURY 31 0.0014
586 CONFUSIONAL STATE 234 0.0014
587 PRESCRIBED OVERDOSE 28 0.0014
588 FOOT DEFORMITY 16 0.0014
589 LIP SWELLING 48 0.0014
590 HEPATIC CIRRHOSIS 27 0.0014
591 BACTERAEMIA 17 0.0014
592 EXPOSURE VIA SKIN CONTACT 37 0.0014
593 VISION BLURRED 196 0.0014
594 HERPES ZOSTER 82 0.0014
595 BONE PAIN 83 0.0014
596 PNEUMONIA BACTERIAL 13 0.0014
597 QUALITY OF LIFE DECREASED 19 0.0014
598 RENAL PAIN 15 0.0014
599 BRAIN NEOPLASM 13 0.0014
600 INCREASED TENDENCY TO BRUISE 13 0.0014
601 BLOOD THYROID STIMULATING HORMONE INCREASED 13 0.0014
602 FEAR 38 0.0014
603 BURNING SENSATION 99 0.0014
604 ROAD TRAFFIC ACCIDENT 59 0.0014
605 SYNCOPE 141 0.0014
606 PARALYSIS 20 0.0014
607 BRAIN INJURY 14 0.0014
608 INFLAMMATION 72 0.0014
609 STAPHYLOCOCCAL INFECTION 46 0.0014
610 HOT FLUSH 105 0.0014
611 NEPHROPATHY 13 0.0014
612 PARANOIA 24 0.0014
613 GINGIVAL BLEEDING 19 0.0014
614 ACUTE HEPATIC FAILURE 19 0.0014
615 FULL BLOOD COUNT DECREASED 28 0.0014
616 SWELLING 130 0.0014
617 MUSCLE TWITCHING 32 0.0014
618 PRODUCT QUALITY ISSUE 188 0.0014
619 HOSPITALISATION 212 0.0014
620 HYPOKINESIA 20 0.0014
621 SWOLLEN TONGUE 43 0.0014
622 BLOOD GLUCOSE DECREASED 66 0.0014
623 PRURITUS 528 0.0014
624 SLUGGISHNESS 14 0.0014
625 ADVERSE DRUG REACTION 123 0.0014
626 ANKYLOSING SPONDYLITIS 18 0.0014
627 SPINAL PAIN 16 0.0014
628 CHILLS 160 0.0014
629 EYE INFLAMMATION 13 0.0014
630 APHASIA 41 0.0014
631 TENDONITIS 21 0.0014
632 FEMUR FRACTURE 42 0.0014
633 BLOOD TEST ABNORMAL 19 0.0014
634 DYSPNOEA 764 0.0013
635 EYE HAEMORRHAGE 18 0.0013
636 VENTRICULAR EXTRASYSTOLES 14 0.0013
637 INFECTION 195 0.0013
638 OEDEMA 73 0.0013
639 MULTIPLE FRACTURES 22 0.0013
640 CONDITION AGGRAVATED 406 0.0013
641 BLOOD PRESSURE SYSTOLIC INCREASED 26 0.0013
642 SKIN FISSURES 26 0.0013
643 CELLULITIS 67 0.0013
644 THYROID CANCER 16 0.0013
645 CLOSTRIDIUM DIFFICILE INFECTION 29 0.0013
646 HYPOAESTHESIA ORAL 20 0.0013
647 BLINDNESS 54 0.0013
648 DEPRESSED MOOD 70 0.0013
649 EPISTAXIS 99 0.0013
650 PNEUMONIA 428 0.0013
651 SWELLING FACE 86 0.0013
652 MELAENA 29 0.0013
653 HYPERTENSION 278 0.0013
654 BODY HEIGHT DECREASED 14 0.0013
655 INCREASED APPETITE 25 0.0013
656 UROSEPSIS 12 0.0013
657 NIGHTMARE 45 0.0013
658 SYSTEMIC LUPUS ERYTHEMATOSUS 46 0.0013
659 TENDON RUPTURE 16 0.0013
660 COUGH 363 0.0013
661 INCORRECT PRODUCT STORAGE 17 0.0013
662 CATARACT 77 0.0013
663 MUSCULOSKELETAL CHEST PAIN 20 0.0013
664 HEPATIC STEATOSIS 24 0.0013
665 PULMONARY THROMBOSIS 14 0.0013
666 CHOKING 25 0.0013
667 ALOPECIA 251 0.0013
668 WHITE BLOOD CELL COUNT INCREASED 49 0.0013
669 VISUAL IMPAIRMENT 158 0.0013
670 RASH PRURITIC 69 0.0013
671 RHINORRHOEA 82 0.0013
672 OCULAR HYPERAEMIA 60 0.0013
673 BLISTER 71 0.0013
674 ATAXIA 15 0.0013
675 SKIN DISCOLOURATION 58 0.0013
676 AMNESIA 82 0.0013
677 EXTRA DOSE ADMINISTERED 51 0.0013
678 ARTHRALGIA 523 0.0013
679 BLOOD CALCIUM INCREASED 11 0.0013
680 STOMATITIS 76 0.0013
681 RASH 545 0.0012
682 EYE PRURITUS 42 0.0012
683 SENSORY DISTURBANCE 20 0.0012
684 GLAUCOMA 24 0.0012
685 OXYGEN SATURATION DECREASED 70 0.0012
686 BLOOD CALCIUM DECREASED 14 0.0012
687 LUNG DISORDER 61 0.0012
688 MUSCULOSKELETAL STIFFNESS 109 0.0012
689 TREATMENT FAILURE 103 0.0012
690 MENTAL IMPAIRMENT 30 0.0012
691 MITRAL VALVE INCOMPETENCE 14 0.0012
692 PSORIATIC ARTHROPATHY 50 0.0012
693 RASH MACULAR 43 0.0012
694 PRODUCT AVAILABILITY ISSUE 28 0.0012
695 SCAB 14 0.0012
696 INTERNAL HAEMORRHAGE 14 0.0012
697 RED BLOOD CELL COUNT DECREASED 35 0.0012
698 CONTRAINDICATED PRODUCT ADMINISTERED 37 0.0012
699 GLOMERULAR FILTRATION RATE DECREASED 15 0.0012
700 MASS 17 0.0012
701 IMMUNE SYSTEM DISORDER 16 0.0012
702 COMPLETED SUICIDE 101 0.0012
703 SKIN CANCER 26 0.0012
704 NEOPLASM MALIGNANT 80 0.0012
705 DYSGEUSIA 89 0.0012
706 HYPERSENSITIVITY 222 0.0012
707 DIPLOPIA 31 0.0012
708 NASOPHARYNGITIS 220 0.0012
709 OBESITY 19 0.0012
710 ECONOMIC PROBLEM 18 0.0012
711 ASPIRATION 13 0.0012
712 DISTURBANCE IN ATTENTION 64 0.0012
713 EYE DISORDER 39 0.0012
714 NERVOUS SYSTEM DISORDER 37 0.0012
715 TOXIC EPIDERMAL NECROLYSIS 18 0.0012
716 SEPSIS 132 0.0012
717 ADVERSE EVENT 109 0.0012
718 JOINT STIFFNESS 31 0.0012
719 PARAESTHESIA 185 0.0012
720 MYOCLONUS 14 0.0012
721 PANCREATITIS 62 0.0012
722 MUSCLE RIGIDITY 14 0.0012
723 SKIN LESION 32 0.0012
724 CARDIAC DISORDER 109 0.0012
725 THERAPY NON-RESPONDER 52 0.0012
726 INCORRECT PRODUCT ADMINISTRATION DURATION 25 0.0012
727 MOVEMENT DISORDER 37 0.0012
728 ANGINA PECTORIS 33 0.0012
729 WHEEZING 68 0.0011
730 URTICARIA 192 0.0011
731 MYALGIA 194 0.0011
732 IRRITABILITY 68 0.0011
733 ATRIAL FIBRILLATION 110 0.0011
734 DRUG INTOLERANCE 109 0.0011
735 HAIR COLOUR CHANGES 14 0.0011
736 AGEUSIA 28 0.0011
737 SKIN ULCER 29 0.0011
738 MENTAL STATUS CHANGES 31 0.0011
739 DEMENTIA 31 0.0011
740 HYPOXIA 39 0.0011
741 UVEITIS 15 0.0011
742 HYPERTHYROIDISM 16 0.0011
743 PRODUCT COMPLAINT 28 0.0011
744 DEVICE RELATED INFECTION 17 0.0011
745 CARDIAC ARREST 91 0.0011
746 PERIPHERAL COLDNESS 15 0.0011
747 SUICIDAL IDEATION 100 0.0011
748 LACRIMATION INCREASED 33 0.0011
749 HEPATIC ENZYME INCREASED 74 0.0011
750 DISORIENTATION 43 0.0011
751 DERMATITIS ATOPIC 57 0.0011
752 HYPERTENSIVE CRISIS 12 0.0011
753 PNEUMOTHORAX 17 0.0011
754 IMPAIRED HEALING 35 0.0011
755 HYPOTENSION 213 0.0011
756 CEREBRAL HAEMORRHAGE 38 0.0011
757 INJECTION SITE URTICARIA 26 0.0011
758 ENCEPHALOPATHY 26 0.0011
759 OEDEMA PERIPHERAL 129 0.0011
760 DIALYSIS 15 0.0011
761 ILL-DEFINED DISORDER 64 0.0011
762 GENERALISED OEDEMA 13 0.0010
763 HAIR TEXTURE ABNORMAL 14 0.0010
764 INFLUENZA LIKE ILLNESS 86 0.0010
765 JOINT RANGE OF MOTION DECREASED 14 0.0010
766 JOINT SWELLING 126 0.0010
767 GASTRIC HAEMORRHAGE 12 0.0010
768 TREATMENT NONCOMPLIANCE 57 0.0010
769 PHARYNGEAL OEDEMA 16 0.0010
770 CLOSTRIDIUM DIFFICILE COLITIS 11 0.0010
771 DYSARTHRIA 39 0.0010
772 ANAPHYLACTIC REACTION 57 0.0010
773 BLOOD CHOLESTEROL INCREASED 48 0.0010
774 BODY TEMPERATURE INCREASED 21 0.0010
775 GENERALISED TONIC-CLONIC SEIZURE 17 0.0010
776 RASH PAPULAR 23 0.0010
777 LIVER DISORDER 45 0.0010
778 FLUSHING 103 0.0010
779 UNRESPONSIVE TO STIMULI 26 0.0010
780 IMMUNODEFICIENCY 15 0.0010
781 HAEMOPTYSIS 28 0.0010
782 DEVICE ISSUE 90 0.0010
783 AGITATION 73 0.0010
784 SEDATION 26 0.0010
785 MUSCULOSKELETAL PAIN 52 0.0010
786 CRYING 36 0.0010
787 SKIN DISORDER 33 0.0010
788 RASH ERYTHEMATOUS 47 0.0010
789 GLOSSODYNIA 22 0.0010
790 DELIRIUM 34 0.0010
791 RENAL IMPAIRMENT 82 0.0010
792 CARDIOMEGALY 12 0.0010
793 CARDIAC FAILURE CONGESTIVE 78 0.0010
794 DRUG INTERACTION 154 0.0010
795 MALIGNANT MELANOMA 13 0.0010
796 HAEMATOMA 25 0.0010
797 DRUG EFFECT INCOMPLETE 35 0.0010
798 APATHY 14 0.0010
799 HAEMATOCRIT DECREASED 19 0.0010
800 BLOOD UREA INCREASED 16 0.0010
801 DERMATITIS 20 0.0010
802 MOOD SWINGS 30 0.0009
803 HEPATIC FUNCTION ABNORMAL 35 0.0009
804 ACUTE RESPIRATORY FAILURE 18 0.0009
805 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 16 0.0009
806 WOUND 26 0.0009
807 RESTLESSNESS 34 0.0009
808 BLOOD COUNT ABNORMAL 14 0.0009
809 HYPONATRAEMIA 52 0.0009
810 DEVICE DISLOCATION 40 0.0009
811 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 31 0.0009
812 ECZEMA 48 0.0009
813 SARS-COV-2 TEST POSITIVE 12 0.0009
814 ABNORMAL BEHAVIOUR 36 0.0009
815 PERICARDIAL EFFUSION 21 0.0009
816 WITHDRAWAL SYNDROME 38 0.0009
817 UNDERDOSE 66 0.0009
818 ARTHROPATHY 50 0.0009
819 CYST 11 0.0009
820 DRY SKIN 118 0.0009
821 HALLUCINATION, AUDITORY 14 0.0009
822 PELVIC PAIN 16 0.0009
823 PSYCHOTIC DISORDER 26 0.0009
824 MOOD ALTERED 24 0.0009
825 BONE DISORDER 16 0.0009
826 ALTERED STATE OF CONSCIOUSNESS 19 0.0009
827 CORONARY ARTERY OCCLUSION 12 0.0009
828 CEREBROVASCULAR ACCIDENT 148 0.0009
829 INFUSION RELATED REACTION 57 0.0009
830 WHITE BLOOD CELL COUNT DECREASED 93 0.0009
831 PULMONARY OEDEMA 38 0.0008
832 ERYTHEMA 174 0.0008
833 FRACTURE 16 0.0008
834 THROMBOSIS 68 0.0008
835 SKIN EXFOLIATION 71 0.0008
836 PYREXIA 290 0.0008
837 HAEMOGLOBIN DECREASED 86 0.0008
838 PULMONARY FIBROSIS 16 0.0008
839 BASAL CELL CARCINOMA 13 0.0008
840 ADVERSE REACTION 11 0.0008
841 PULMONARY ARTERIAL HYPERTENSION 12 0.0008
842 NEEDLE ISSUE 24 0.0008
843 ANAEMIA 156 0.0008
844 PALLOR 22 0.0008
845 INJECTION SITE BRUISING 64 0.0008
846 CENTRAL NERVOUS SYSTEM LESION 11 0.0008
847 DIABETES MELLITUS 61 0.0008
848 ALANINE AMINOTRANSFERASE INCREASED 49 0.0008
849 BLOOD CREATININE INCREASED 52 0.0008
850 IMPAIRED WORK ABILITY 17 0.0008
851 LIVER FUNCTION TEST INCREASED 17 0.0008
852 MANIA 13 0.0008
853 CARDIAC FAILURE 63 0.0008
854 TARDIVE DYSKINESIA 22 0.0008
855 LABORATORY TEST ABNORMAL 23 0.0008
856 GASTROINTESTINAL HAEMORRHAGE 65 0.0008
857 TYPE 2 DIABETES MELLITUS 26 0.0008
858 ASPARTATE AMINOTRANSFERASE INCREASED 41 0.0008
859 HEMIPARESIS 13 0.0008
860 BLOOD GLUCOSE ABNORMAL 14 0.0008
861 INJECTION SITE SWELLING 58 0.0008
862 GASTROENTERITIS 11 0.0008
863 GLYCOSYLATED HAEMOGLOBIN INCREASED 19 0.0008
864 INJECTION SITE RASH 23 0.0007
865 PREGNANCY 15 0.0007
866 BREAST CANCER FEMALE 20 0.0007
867 EMOTIONAL DISORDER 23 0.0007
868 PLEURAL EFFUSION 45 0.0007
869 DEVICE BREAKAGE 30 0.0007
870 BLOOD GLUCOSE INCREASED 139 0.0007
871 DRUG ERUPTION 13 0.0007
872 DEATH 630 0.0007
873 INJECTION SITE REACTION 50 0.0007
874 CORONARY ARTERY DISEASE 22 0.0007
875 OSTEOMYELITIS 13 0.0007
876 CARDIO-RESPIRATORY ARREST 30 0.0007
877 ACCIDENTAL OVERDOSE 26 0.0007
878 ANGER 24 0.0007
879 HAEMORRHAGE 74 0.0007
880 ACTIVITIES OF DAILY LIVING IMPAIRED 14 0.0007
881 PSORIASIS 92 0.0007
882 INJECTION SITE MASS 26 0.0007
883 DISEASE RECURRENCE 33 0.0007
884 ABSCESS 11 0.0007
885 DEVICE USE ISSUE 12 0.0007
886 BLOOD ALKALINE PHOSPHATASE INCREASED 17 0.0007
887 HYPOGLYCAEMIA 33 0.0007
888 RHEUMATOID ARTHRITIS 77 0.0007
889 PRODUCT SUBSTITUTION ISSUE 39 0.0007
890 TOOTH LOSS 14 0.0007
891 PULMONARY HYPERTENSION 14 0.0007
892 PRODUCT ADHESION ISSUE 24 0.0007
893 COLITIS ULCERATIVE 30 0.0007
894 EMOTIONAL DISTRESS 81 0.0007
895 RESPIRATORY ARREST 18 0.0007
896 INCORRECT DOSE ADMINISTERED BY DEVICE 17 0.0006
897 CYTOKINE RELEASE SYNDROME 13 0.0006
898 PLATELET COUNT DECREASED 69 0.0006
899 CONJUNCTIVITIS 12 0.0006
900 ASCITES 19 0.0006
901 DEEP VEIN THROMBOSIS 42 0.0006
902 SEPTIC SHOCK 28 0.0006
903 INJECTION SITE PRURITUS 43 0.0006
904 BONE DENSITY DECREASED 20 0.0006
905 NEUTROPHIL COUNT DECREASED 26 0.0006
906 ARRHYTHMIA 30 0.0006
907 HYPERGLYCAEMIA 23 0.0006
908 TACHYCARDIA 56 0.0006
909 INJURY 44 0.0006
910 RASH GENERALISED 16 0.0006
911 INJECTION SITE PAIN 188 0.0006
912 DEVICE MALFUNCTION 43 0.0006
913 MEDICATION ERROR 34 0.0006
914 LUNG NEOPLASM MALIGNANT 25 0.0006
915 INCORRECT DRUG ADMINISTRATION DURATION 17 0.0006
916 ACCIDENTAL EXPOSURE TO PRODUCT 62 0.0006
917 DEVICE LEAKAGE 26 0.0006
918 LOWER RESPIRATORY TRACT INFECTION 27 0.0006
919 EPILEPSY 18 0.0006
920 PNEUMONITIS 16 0.0006
921 ANAPHYLACTIC SHOCK 15 0.0006
922 INJECTION SITE ERYTHEMA 72 0.0006
923 ACNE 44 0.0006
924 RESPIRATORY DISTRESS 16 0.0006
925 INTENTIONAL DRUG MISUSE 12 0.0006
926 CEREBRAL INFARCTION 14 0.0006
927 DYSTONIA 11 0.0006
928 INJECTION SITE HAEMORRHAGE 45 0.0006
929 METABOLIC ACIDOSIS 18 0.0006
930 DEPRESSED LEVEL OF CONSCIOUSNESS 22 0.0006
931 PULMONARY EMBOLISM 51 0.0005
932 MULTIPLE ORGAN DYSFUNCTION SYNDROME 15 0.0005
933 HAEMATURIA 18 0.0005
934 MYOCARDIAL INFARCTION 91 0.0005
935 GENERAL PHYSICAL HEALTH DETERIORATION 60 0.0005
936 HYPERKALAEMIA 18 0.0005
937 CARDIOVASCULAR DISORDER 13 0.0005
938 APPLICATION SITE PAIN 11 0.0005
939 NO ADVERSE EVENT 89 0.0005
940 OSTEONECROSIS OF JAW 12 0.0005
941 BLOOD BILIRUBIN INCREASED 13 0.0005
942 RESPIRATORY FAILURE 35 0.0005
943 DRUG-INDUCED LIVER INJURY 15 0.0005
944 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 14 0.0005
945 GASTRIC CANCER 12 0.0005
946 C-REACTIVE PROTEIN INCREASED 17 0.0005
947 AGGRESSION 23 0.0005
948 INTERNATIONAL NORMALISED RATIO INCREASED 13 0.0005
949 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 21 0.0004
950 DISEASE PROGRESSION 53 0.0004
951 JAUNDICE 12 0.0004
952 ABASIA 11 0.0004
953 TOXICITY TO VARIOUS AGENTS 75 0.0004
954 PLASMA CELL MYELOMA 17 0.0004
955 DRUG RESISTANCE 11 0.0004
956 DRUG ADMINISTRATION ERROR 13 0.0004
957 SKIN BURNING SENSATION 30 0.0004
958 BREAST CANCER 39 0.0004
959 ELECTROCARDIOGRAM QT PROLONGED 15 0.0004
960 VAGINAL HAEMORRHAGE 18 0.0004
961 LIVER FUNCTION TEST ABNORMAL 12 0.0004
962 ACUTE MYOCARDIAL INFARCTION 12 0.0004
963 NEOPLASM PROGRESSION 14 0.0004
964 SUICIDE ATTEMPT 24 0.0004
965 OVERDOSE 85 0.0004
966 EXPOSURE DURING PREGNANCY 24 0.0004
967 ANGIOEDEMA 17 0.0004
968 BLOOD CREATINE PHOSPHOKINASE INCREASED 11 0.0004
969 ABORTION SPONTANEOUS 15 0.0004
970 INTENTIONAL OVERDOSE 24 0.0004
971 VISUAL ACUITY REDUCED 12 0.0004
972 MALIGNANT NEOPLASM PROGRESSION 35 0.0003
973 DEVICE DIFFICULT TO USE 22 0.0003
974 DRUG WITHDRAWAL SYNDROME 28 0.0003
975 COMA 15 0.0003
976 RHABDOMYOLYSIS 13 0.0003
977 INTERSTITIAL LUNG DISEASE 14 0.0003
978 THROMBOCYTOPENIA 31 0.0003
979 SKIN IRRITATION 12 0.0003
980 MATERNAL EXPOSURE DURING PREGNANCY 23 0.0003
981 DRUG DOSE OMISSION BY DEVICE 19 0.0002
982 PANCYTOPENIA 13 0.0002
983 NEUTROPENIA 31 0.0002
984 BRADYCARDIA 12 0.0002
985 PROSTATE CANCER 18 0.0002
986 FEBRILE NEUTROPENIA 14 0.0002
987 DRUG DEPENDENCE 26 0.0002
988 DRUG ABUSE 12 0.0001